HERON THERAPEUTICS, INC. /DE/ Inventory, Finished Goods, Net of Reserves
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Inventory, Finished Goods, Net of Reserves of $8.22 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-10
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $8.22M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $10.36M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $6.88M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $10.90M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $8.22M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $10.36M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $6.88M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $10.90M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $11.00M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $8.47M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $6.24M 10-K · filed 2026-02-26 |
| 2024-09-30 | $6.78M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.22M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $8.11M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $9.92M 10-K · filed 2025-02-27 |
| 2023-09-30 | $9.97M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $17.19M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $17.74M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $18.71M 10-K · filed 2024-03-12 |
| 2022-09-30 | $22.03M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $19.37M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $17.52M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $6.25M 10-K · filed 2023-03-29 |
| 2021-09-30 | $8.97M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $7.08M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.31M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $16.06M 10-K · filed 2022-02-28 |
| 2020-09-30 | $11.44M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.64M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.93M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $5.76M 10-K · filed 2021-02-24 |
| 2019-09-30 | $3.25M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.89M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $7.27M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.32M 10-K · filed 2020-03-02 |
| 2018-09-30 | $8.77M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $9.50M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $6.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.19M 10-K · filed 2019-02-22 |
| 2017-09-30 | $2.50M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $2.10M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.00M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.59M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |